Abstract: A method is provided for inserting an ophthalmological implant between a sclera and a uveal tissue in an eye of a patient. The method includes providing an ophthalmological implant having an anterior edge intended to face the anterior chamber and an posterior edge opposite the anterior edge, and making at least one opening in a corneal tissue. An opening is made in the iris root to form an insertion channel and the ophthalmological implant is inserted through the insertion channel. The ophthalmological implant is positioned between a sclera and a uveal tissue at a position, where the anterior edge of the ophthalmological implant is located in or beyond the insertion channel. The insertion channel is closed so that an iris tissue is disposed between the anterior edge and an anterior chamber of the eye of the patient.

Abstract: The invention relates to a permanent interpositional ophthalmological implant between the sclera and the uveal tis-sue. The implant comprises a thin uvea-compatible body (50) having a thickness (e) which is at least less than IO times the smallest of the two other dimensions of the body, the body of the implant comprising two opposing edges separated from one another along one of the two dimensions perpendicular to the thickness, and one of the edges, known as the front edge (52), being curved in a concave manner away from body in a plane perpendicular to the thickness.

Abstract: The invention relates to a permanent interpositional ophthalmological implant between the sclera and the uveal tis-sue. The implant comprises a thin uvea-compatible body (50) having a thickness (e) which is at least less than IO times the smallest of the two other dimensions of the body, the body of the implant comprising two opposing edges separated from one another along one of the two dimensions perpendicular to the thickness, and one of the edges, known as the front edge (52), being curved in a concave manner away from body in a plane perpendicular to the thickness.

Abstract: A method of treating glaucoma or other eye disease in a patient is provided. The method includes injecting an eye of the patient with a cohesive monophasic gel containing cross-linked hyaluronic acid or its salt. The injection can be under the scleral flap and/or conjunctiva of the eye, thereby creating and maintaining a conjunctival bleb, and/or the injection can be in the supra-scleral and/or supra-choroidal (sub-scleral) space of the eye thereby reducing the intraocular pressure.

Abstract: A method of treating glaucoma or other eye disease in a patient is provided. The method includes injecting an eye of the patient with a cohesive monophasic gel containing cross-linked hyaluronic acid or its salt. The injection can be under the scleral flap and/or conjunctiva of the eye, thereby creating and maintaining a conjunctival bleb, and/or the injection can be in the supra-scleral and/or supra-choroidal (sub-scleral) space of the eye thereby reducing the intraocular pressure.

Abstract: The invention concerns a pre-descemetic sclero-keratectomy implant, designed for exerting a pressure on the pre-descemetic plane and on the stroma during a surgical treatment of glaucoma. The implant is made of crosslinked hyaluronic acid and has substantially the shape of a polyhedron with at least five faces, advantageously with five or six faces. In preferred embodiments, the implant has the shape of a prism, advantageously straight with a base shape as a triangle or parallelepiped, advantageously straight and preferably rectangular.

Abstract: The invention concerns an implant for deep sclerectomy for draining aqueous humor during surgical treatment of glaucoma. The implant is made of crosslinked hyaluronic acid and has substantially the shape of a polyhedron with at least five faces, advantageously the shape of a polyhedron with five or six faces. In a preferred embodiment, the implant has substantially the shape of a prism, advantageously straight with a trapezoidal base.

Abstract: The invention concerns an intraocular implant comprising a substantially circular optical part (10) and two curved haptic loops (12, 14) each with a first connecting end (12a, 14a) at the periphery of the optical part and a free second end (12b, 14b) intended to come to rest on the internal wall of the eye, characterized in that the optical part (10) and the haptic loops (12, 14) are made of the same flexible material, the elastic modulus thereof being in a range between 0.25 MPa and 1 MPa, and in that the width of each loop decreases from its connecting end to its free end such that the ratio between the bending moment variation and the inertia moment variation at two separate points (P1, P2) of the loop is substantially constant.

Abstract: The invention relates to a method for automatic control of means for adjusting an apparatus for observing a subject in the sight of at least one person.